Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort

Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort

Pathological complete response and prognosis after neoadjuvant chemotherapy for <i>HER2</i>-positive breast cancers before and after trastuzumab era: results from a real-life cohort, Published online: 20 February 2018; doi:10.1038/bjc.2018.4

Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort

http://ift.tt/2EFsP1U